Haematology Department at American Oncology Institute (AOI) Nagpur Successfully Treated the First International Patient Kumar Jeetendra | September 12, 2022 12th Sept 2022: A 67-year-old male who was also suffering from Type 2 Diabetes Mellitus got a new lease of life after she was timely treated and successfully cured for Acquired Aplastic Anemia (AA), a rare, life-threatening blood disorder. The condition causes when the body stops producing enough new blood cells. The international patient was …
Alembic Gets USFDA Nod for Doxorubicin Liposome Injection Kumar Jeetendra | June 30, 2025 30th June, 2025 Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials. The approved ANDA is therapeutically equivalent …
